US 9090589
Specific nNOS inhibitors for the therapy and prevention of human melanoma
granted A61KA61K31/4439A61P
Quick answer
US patent 9090589 (Specific nNOS inhibitors for the therapy and prevention of human melanoma) held by The Regents of the University of California expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/4439, A61P, A61P35/00